戴苑竹
Lv1
68 积分
2022-11-04 加入
-
Reprogramming site-specific retrotransposon activity to new DNA sites
1天前
已完结
-
Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BMS-986353 (CC-97540), a CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy Manufactured Using a Next-Generation Process, for Severe, Refractory Autoimmune Diseases: Updated Data from Ongoing Phase 1, Multicenter, Open-Label Studies
26天前
已关闭
-
Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders
2个月前
已完结
-
Rewriting endogenous human transcripts withtrans-splicing
7个月前
已完结
-
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
8个月前
已完结
-
Can autoimmune diseases be cured? Scientists see hope at last
8个月前
已完结
-
The rise of precision cellular therapies
8个月前
已完结
-
Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis
8个月前
已完结
-
Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaques
8个月前
已完结
-
Strategies to reduce the risks of mRNA drug and vaccine toxicity
8个月前
已完结